Calgary, AB
Canada
10
2022-04-21
9
2018-07-03
These are the the leading inventors for applications assigned to Zenith Epigenetics Ltd.:
Zenith Epigenetics Ltd. based in Calgary, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
COMBINATION THERAPY FOR THE TREATMENT OF PROSTATE CANCER
#2 | 2017-08-03 ✅ Patent 10,010,556 granted on 2018-07-03Bicyclic bromodomain inhibitors
#3 | 2017-08-03 ✅ Patent 9,999,616 granted on 2018-06-19Substituted bicyclic compounds as bromodomain inhibitors
#4 | 2017-05-25 ✅ Patent 9,861,637 granted on 2018-01-09Heterocyclic compounds as bromodomain inhibitors
#5 | 2016-07-07 ✅ Patent 9,855,271 granted on 2018-01-02Quinazolinones as bromodomain inhibitors
#6 | 2016-06-30 ✅ Patent 9,662,311 granted on 2017-05-30Substituted bicyclic compounds as bromodomain inhibitors
#7 | 2016-06-09 ✅ Patent 9,663,520 granted on 2017-05-30Bicyclic bromodomain inhibitors
#8 | 2016-05-26 ✅ Patent 9,636,328 granted on 2017-05-02Substituted bicyclic compounds as bromodomain inhibitors
#9 | 2016-05-12 ✅ Patent 9,598,367 granted on 2017-03-21Heterocyclic compounds as bromodomain inhibitors
#10 | 2014-05-22 ✅ Patent 9,765,039 granted on 2017-09-19Biaryl derivatives as bromodomain inhibitors
322685 ⎘